Abnormal movement in US stock market | Thermo Fisher Scientific (TMO.US) surges by 11%, Q2 revenue exceeds expectations.

According to the Smart Financial News APP, on Wednesday, Thermo Fisher Scientific (TMO.US) soared 11%, closing at $474.67. In terms of news, in the second quarter, Thermo Fisher Scientific's revenue increased by 3% to $10.85 billion, while analysts had expected $10.68 billion. Sales in the laboratory products division accounted for more than half of the company's total sales, reaching $6 billion, higher than the expected $5.79 billion. Earnings per share were $5.36, exceeding analysts' expected $5.22 per share. Due to strong demand in the industry for tools and services used in the production of vaccines and therapies, the company's profits exceeded expectations.